These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 6797089)
61. Ticlopidine - an antiplatelet drug: effects in human volunteers. O'Brien JR; Etherington MD; Shuttleworth RD Thromb Res; 1978 Aug; 13(2):245-54. PubMed ID: 694843 [No Abstract] [Full Text] [Related]
62. Factor VIII and human platelet aggregation. IV. Effect of proteolytic enzymes on platelet aggregation by factor VIII. Vermylen J; Bottecchia D Br J Haematol; 1976 Oct; 34(2):331-40. PubMed ID: 135576 [TBL] [Abstract][Full Text] [Related]
63. Effects of long term administration of ticlopidine on platelet function and hemostatic variables. Conard J; Lecrubier C; Scarabin PY; Horellou MH; Samama M; Bousser MG Thromb Res; 1980 Oct; 20(1):143-8. PubMed ID: 7209871 [No Abstract] [Full Text] [Related]
64. Quantitative and functional changes in platelets and their preservation during extracorporeal circulation. Miyauchi Y; Isomura K J Cardiovasc Surg (Torino); 1982; 23(5):383-90. PubMed ID: 7130259 [TBL] [Abstract][Full Text] [Related]
65. Comparison between the antiaggregating effect of ticlopidine in whole blood, platelet-rich plasma and washed platelets of the rat. Randon J; Lefort J; Vargaftig BB Thromb Res; 1982 Apr; 26(1):13-20. PubMed ID: 7048623 [TBL] [Abstract][Full Text] [Related]
66. [Thrombocytopenia due to antibodies induced by ticlopidine]. Claas FH; de Fraiture WH; Meyboom RH Nouv Rev Fr Hematol (1978); 1984; 26(5):323-4. PubMed ID: 6504695 [TBL] [Abstract][Full Text] [Related]
67. [Ability of vancomycin-group antibiotics to induce or to inhibit thrombocyte agglutination]. Rák K; Boda Z; Sztaricskai F Antibiotiki; 1980 Aug; 25(8):595-606. PubMed ID: 6250464 [TBL] [Abstract][Full Text] [Related]
68. Function and ultrastructure of platelets of neonates: enhanced ristocetin aggregation of neonatal platelets. Ts'ao CH; Green D; Schultz K Br J Haematol; 1976 Feb; 32(2):225-33. PubMed ID: 1247495 [TBL] [Abstract][Full Text] [Related]
69. A double-blind trial of ticlopidine in sickle cell disease. Semple MJ; Al-Hasani SF; Kioy P; Savidge GF Thromb Haemost; 1984 Jul; 51(3):303-6. PubMed ID: 6388012 [TBL] [Abstract][Full Text] [Related]
70. A plasma inhibitor of ristocetin-induced platelet aggregation in patients with sickle hemoglobinopathies. Leichtman DA; Brewer GJ Am J Hematol; 1977; 2(3):251-8. PubMed ID: 596369 [TBL] [Abstract][Full Text] [Related]
71. Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective. de Gaetano G; Bertelé V Arq Bras Cardiol; 1983 Dec; 41(6):425-7. PubMed ID: 6678584 [No Abstract] [Full Text] [Related]
72. Comparative study of platelet aggregation measured with 3 different methods (photometric and impedance) in ticlopidine treated patients. Lecrubier C; Girard P; Noire P; Samama M Agents Actions Suppl; 1984; 15():60-7. PubMed ID: 6592946 [No Abstract] [Full Text] [Related]
73. Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states. Saltiel E; Ward A Drugs; 1987 Aug; 34(2):222-62. PubMed ID: 3304967 [TBL] [Abstract][Full Text] [Related]
74. Borate and glycerol inhibition of the aggregation of guinea pig platelets by bovine factor VIII and ristocetin. Kuwahara SS Am J Hematol; 1977; 2(2):159-72. PubMed ID: 888824 [TBL] [Abstract][Full Text] [Related]
75. Spin label study of the effect of ticlopidine on platelets. Hongo T; Setaka M; Kwan T Jpn J Pharmacol; 1985 Sep; 39(1):59-66. PubMed ID: 2999489 [TBL] [Abstract][Full Text] [Related]